Biological agents in the treatment of psoriasis

Giornale Italiano di Dermatologia e Venereologia

Volumn 140, Issue 5, 2005, Pages 557-560

  Rausin, A ^a   Henno, A ^a   De La Brassinne, M ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Biology; Psoriasis, immunology; T lymphocytes

Indexed keywords

ADALIMUMAB; ALEFACEPT; BASILIXIMAB; BIOLOGICAL PRODUCT; CYTOKINE; DACLIZUMAB; EFALIZUMAB; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; ONERCEPT; TUMOR NECROSIS FACTOR ALPHA; ZENAPRAX;

ANAPHYLAXIS; APLASTIC ANEMIA; CELLULAR IMMUNITY; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DEMYELINATION; DRUG APPROVAL; DRUG MECHANISM; DRUG RECEPTOR BINDING; FLU LIKE SYNDROME; HEADACHE; HEART FAILURE; HEART PALPITATION; HUMAN; HUMORAL IMMUNITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOMODULATION; INFECTION; INJECTION SITE REACTION; LUPUS LIKE SYNDROME; NAUSEA; NEOPLASM; OPPORTUNISTIC INFECTION; PANCYTOPENIA; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIA; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 33745425177     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis:immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol 2004;151:3-15.
2. Mendonça CO, Griffiths CEM. Side effects of systemic treatment for psoriasis. Retinoids 2004;20:98-101.
3. Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E et al. Biological therapies in the systemic management of psoriasis: international consensus conference. Br J Dermatol 2004;151 Suppl 69:3-17.
4. Schleyer V, Landthaler M, Szeimies R-M. Novel pharmacological approaches in the treatment of psoriasis. J Eur Acad Dermatol Venereol 2005;19:1-20.
5. Mendonça CO, Burden AD. Current concepts in psoriasis and its treatment. Pharmacol Ther 2003;99:133-47.
6. Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003;349:2014-22.
7. Krueger G, Callis K. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis. Arch Dermatol 2004;140: 218-25.
8. Benoit S, Toksoy A, Bröcker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br J Dermatol 2004;150:1009-12.